课题基金 / 基金详情

Molecular biological studies on the formation of atherogenic small dense low density lipoprotein (sLDL)

Molecular biological studies on the formation of atherogenic small dense low density lipoprotein (sLDL)
致动脉粥样硬化小致密低密度脂蛋白(sLDL)形成的分子生物学研究
批准号:
06671066
负责人:
IKEDA Yasuyuki
金额:
$1.34万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

IKEDA Yasuyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have systematically investigated the mechanism of formation of small dense low density lipoprotein (sLDL) in the circulation which is known to be one of risk factors for atherosclerosis. As sLDL is high frequently found on patients with type IV hypertriglyceridemia, we first attempted to clarify an underlying etiology of type IV hypertriglyceridemia by monitoring LPL immunoreactive mass in postheparin plasma of 32 non-diabetic patients with type IV hypertriglyceridemia using our sandwich-EIA technique for the first screenig, followed by a second screening for LPL gene aberrations using PCR-SSCP and direct sequencing methods. By this approach, we found that heterozygous LPL deficiency was an underlying genetic disorder of type IV hypertriglyceridemia, and that subjects with heterozygous LPL deficiency are prone to manifest type IV hypertriglyceridemia when they acquire triglyceride (TG) synthesis stimulating factors like high alcohol intake.In order to understand the mechanism of the formation of sLDL under hypertriglyceridemia, lipoproteins isolated from 30 subjects with type IV hypertriglyceridemia and 30 normal subjects were compared. The ratio of TG over cholesterol ester (CE) in HDL (HDL-TG/CE) was correlated with serum TG concentration derived from TG-rich lipoproteins such as VLDL.Factors correlating with LDL size variation were further searched, and the variation of LDL size was reversely correlated with HDL-TG/CE ratio and hepatic triglyceride lipase (HTGL) immunoreactive mass in PHP.These statistical data were confirmed by in vitro experiments in which lipid composition of HDL is changed into TG-rich and CE-poor particle via lipid transfer protein action by interacting with high amount of VLDL corresponding to type IV hypertriglyceridemia, and LDL is converted into TG-rich and CE-poor particle by interacting with TG-rich/CE-poor HDL,and in the final step TG hydrolysis of LDL by HTGL action results in the formation of sLDL.
期刊论文(92)
专著(0)
科研奖励(0)
会议论文
A.Yamamoto: "Multiple Risk Factors in Cardiovascular Disease" Churchill Livingstone,Japan, 277 (1994)
A.Yamamoto:“心血管疾病的多种危险因素”Churchill Livingstone,日本,277 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Ikeda, A.Takagi, A.Yamamoto: "Elucidation of an underlying etiology of primary type IV hyperlipoproteinemia : heterozygous lipoprotein lipase deficiency as a casual genetic disorder." In : Current Advances in Triglycerides and Atherosclerosis (ED.by A.Y
Y.Ikeda、A.Takagi、A.Yamamoto:“阐明原发性 IV 型高脂蛋白血症的潜在病因:杂合性脂蛋白脂肪酶缺乏症是一种偶然的遗传性疾病。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高木敦子: "リポ蛋白リパーゼ(LDL)." 日本臨床. 53. 639-643 (1995)
Atsuko Takagi:“脂蛋白脂肪酶 (LDL)”,日本临床 53. 639-643 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    動脈硬化性疾患の発症に直結する新規バイオマーカーの発見と早期診断・治療法の開発
    Establishment of genetic diagnostics, preventive and development of treatment for atherogenic hypertriglyceridemia
    Establishment of an early diagnostic system for the detection of heart disease-related gene mutations with a novel electrochemical array chip
    Development and application of DNA tip for the diagnosis of atherogenic hypertriglyceridemia
    海外基金